Palantir & AI operating systems
Apply connected data, applications, and governed AI workflows to pharmaceutical business and operational processes.
Pharma teams often need to connect fragmented operational data, approvals, analytics, documents, and cross-functional workflows under strong governance.
Introduction
Palantir concepts for pharmaceutical operations in practice.
Pharmaceutical organizations operate under governance requirements that make the architecture question sharper than in most sectors. Connected data, applications, and governed AI workflows are valuable, but only where traceability and validation requirements can be met.
The productive starting point is non-clinical operational work: coordination, document handling, approvals, and cross-functional workflows where evidence and auditability are clear and regulated decision-making is not involved.
Common failure modes
- Start with non-clinical operational workflows where evidence and auditability are clear.
- Point tools that separate data, applications, and actions
- AI initiatives that stop at answers instead of operational outcomes
The problem
Why the current approach stops scaling.
Operational data in pharma is fragmented across functions and often duplicated for compliance reasons. Cross-functional workflows therefore involve manual assembly and re-verification, which is slow and itself a source of error.
The second problem is documentation burden. Approvals, sign-offs, and evidence trails are mandatory and largely manual, which consumes capacity from people whose expertise is needed elsewhere.
You're likely here because
- Cross-functional operational workflows depend on manual assembly
- Documentation and approval trails consume expert capacity
- Governance requirements make ad-hoc tooling unacceptable
Workflow
How the work actually runs, step by step.
Step 01
Choose a non-regulated workflow
Start where the decision content is operational and the audit requirements are clear rather than contested.
Step 02
Connect the source systems
Bring the relevant operational systems into governed reach with permissions and provenance recorded.
Step 03
Structure the approvals
Give approvals explicit states, owners, thresholds, and an audit trail generated by the workflow itself.
Step 04
Keep human review where required
Any step with regulatory weight retains an accountable human decision, with the supporting evidence attached.
Architecture
The layers underneath the workflow.
Step 01
Governed data access
Scoped connections with provenance, because the source of a figure matters as much as the figure.
Step 02
Workflow and approvals
Explicit states and approval gates that produce an audit trail as a by-product.
Step 03
Operational surfaces
Cross-functional views assembled from connected systems rather than from re-keyed data.
Step 04
Traceability
Complete records of inputs, decisions, and actions, which is a baseline requirement in this sector.
Implementation path
What implementation looks like.
- 01
Confirm the validation and audit requirements that apply to the candidate workflow before building.
- 02
Select a workflow with clear boundaries and no regulated decision content.
- 03
Connect systems with scoped permissions and provenance recorded from the start.
- 04
Build the workflow with approval gates and a native audit trail.
- 05
Review with quality and compliance stakeholders before extending to adjacent processes.
Controls
Controls that matter.
Control 01
Traceability, permissions, and source-data provenance as design requirements, not enhancements.
Control 02
Human review retained wherever regulatory accountability applies.
Control 03
Explicit separation between operational automation and regulated decision-making.
Examples
Worked examples.
Cross-functional document workflow
Document requests, reviews, and approvals get explicit states and owners with the audit trail produced by the workflow, replacing an email-and-spreadsheet process that had to be reconstructed for every audit.
Operational reporting with provenance
A recurring operational report is assembled from connected sources with lineage retained, so each figure can be traced to its source rather than defended from memory.
Evidence that has to survive an audit
In regulated commercial operations the question is rarely whether an action can be automated, but whether you can reconstruct afterwards who authorised it and on what basis. Designing for that reconstruction first is what makes the automation approvable.
Limitations and considerations
Limitations and considerations.
- Regulated processes carry validation requirements that general-purpose software does not satisfy by default.
- Data segregation and access requirements are strict and constrain what can be connected.
- Change control processes make iteration slower than in unregulated sectors.
- Clinical, safety, and regulatory decisions stay with qualified accountable humans.
- Regulated promotional and medical activity has review requirements that automation does not remove. Faster production of material that still needs approval moves the queue, not the constraint.
- Validation obligations in this sector can make change slow by design. An approach that assumes rapid iteration may be a poor fit regardless of its merits.
FAQ
Questions people ask.
What matters most for AI workflows in pharma?
Traceability, permissions, source data, human review where required, and clear separation between operational automation and regulated decision-making.
Where should pharma start?
Non-clinical operational workflows — document handling, approvals, cross-functional coordination — where audit requirements are well understood.
Can AI participate in regulated decisions?
Not as the decision-maker. It can assemble and present evidence while accountability remains with qualified humans under the applicable validation regime.
Is automated outreach appropriate here?
Only inside the review requirements that already govern it. The useful automation is usually upstream — research, coordination, and evidence collection — rather than the message itself.
What matters most in the design?
Provenance. Every automated action needs to carry what triggered it, which data it used and who authorised the pattern, because that is what a review will ask for.
Product path
Where this runs inside UbiVibe.
ARIA holds the operating context, Launch turns the requirement into working software, and Grow carries the commercial execution against the same connected records.
Build with Launch
Turn the operating requirement into working software.
- • Operational dashboards
- • Cross-functional tools
- • Governed workflows
Operate with Grow
Keep the workflow connected after the interface exists.
- • Connect CRM, email, calendar, and pipeline context
- • Turn recommendations into bounded revenue actions
- • Keep outreach, meetings, pipeline, and attribution in one operating context
Connected context
Keep systems of record. Fix the gaps between them.
These are representative connections. UbiGrowth supports 700+ connections across business systems. Connection availability and permissions depend on workspace configuration.
Test the business case with your own operating assumptions.
Use the ROI calculator to model lead volume, close rate, deal value, and manual workload rather than relying on a generic outcome claim.
Open the ROI calculator →Start with ARIA
Put it to work on your own data.
Describe the outcome you want. ARIA establishes the operating context, selects the capabilities it needs, and runs the execution against the systems you already use.
- ARIA acts only through the systems and permissions you connect.
- Connections use scoped credentials you can change or revoke.
- Actions are recorded, and consequential ones can require approval.
Start here
Put palantir concepts for pharmaceutical operations to work on your own data.
Start with ARIA to establish the operating context, then build the surface and run the execution against the systems you already use.